DE69628117D1 - Antifungale tetrahydrofurane - Google Patents

Antifungale tetrahydrofurane

Info

Publication number
DE69628117D1
DE69628117D1 DE69628117T DE69628117T DE69628117D1 DE 69628117 D1 DE69628117 D1 DE 69628117D1 DE 69628117 T DE69628117 T DE 69628117T DE 69628117 T DE69628117 T DE 69628117T DE 69628117 D1 DE69628117 D1 DE 69628117D1
Authority
DE
Germany
Prior art keywords
tetrahydrofurane
antifungal
antifungal tetrahydrofurane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69628117T
Other languages
English (en)
Other versions
DE69628117T2 (de
Inventor
K Saksena
M Girijavallabhan
G Lovey
E Pike
Haiyan Wang
Yi-Tsung Liu
K Ganguly
Frank Bennett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/459,225 external-priority patent/US5710154A/en
Priority claimed from US08/458,543 external-priority patent/US5714490A/en
Priority claimed from US08/459,145 external-priority patent/US5693626A/en
Application filed by Schering Corp filed Critical Schering Corp
Publication of DE69628117D1 publication Critical patent/DE69628117D1/de
Application granted granted Critical
Publication of DE69628117T2 publication Critical patent/DE69628117T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
DE69628117T 1995-06-02 1996-05-30 Antifungale tetrahydrofurane Expired - Lifetime DE69628117T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US458543 1974-04-08
US08/459,225 US5710154A (en) 1993-12-21 1995-06-02 Tetrahydrofuran antifungals
US08/458,543 US5714490A (en) 1993-12-21 1995-06-02 Tetrahydrofuran antifungals
US459145 1995-06-02
US08/459,145 US5693626A (en) 1993-12-21 1995-06-02 Tetrahydrofuran antifungals
US459225 1995-06-02
PCT/US1996/007547 WO1996038443A1 (en) 1995-06-02 1996-05-30 Tetrahydrofuran antifungals

Publications (2)

Publication Number Publication Date
DE69628117D1 true DE69628117D1 (de) 2003-06-18
DE69628117T2 DE69628117T2 (de) 2004-04-01

Family

ID=27412736

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69628117T Expired - Lifetime DE69628117T2 (de) 1995-06-02 1996-05-30 Antifungale tetrahydrofurane

Country Status (19)

Country Link
EP (1) EP0773941B1 (de)
CN (1) CN1073109C (de)
AR (1) AR002751A1 (de)
AT (1) ATE240319T1 (de)
AU (1) AU5928096A (de)
CA (1) CA2197672C (de)
CZ (1) CZ59497A3 (de)
DE (1) DE69628117T2 (de)
ES (1) ES2199291T3 (de)
HK (1) HK1008821A1 (de)
HU (1) HUP9701690A3 (de)
IL (1) IL118464A (de)
MX (1) MX9701229A (de)
NO (1) NO971218D0 (de)
NZ (1) NZ309281A (de)
PL (1) PL319635A1 (de)
SK (1) SK27097A3 (de)
TW (1) TW357146B (de)
WO (1) WO1996038443A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100509171B1 (ko) 1997-02-11 2005-08-22 얀센 파마슈티카 엔.브이. 아미노산 에스테르를 포함하는 아졸 항진균제
AU9592998A (en) * 1997-10-07 1999-04-27 Schering Corporation Crystalline antifungal glycine ester polymorph
ATE263163T1 (de) * 1997-10-07 2004-04-15 Schering Corp Krytallinischer fungizider polymorph
US6713481B1 (en) * 1997-10-17 2004-03-30 David R. Andrews Crystalline antifungal polymorph
US5883097A (en) * 1998-04-16 1999-03-16 Schering Corporation Soluble azole antifungal salt
EP0957101A1 (de) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Wasserlösliche Azole als Breitspektrum-antifungus
WO2000030655A1 (en) 1998-11-20 2000-06-02 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
ID30409A (id) 1999-05-04 2001-11-29 Jannsen Pharmaceutica N V Eter anti jamur
US6362172B2 (en) 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6448401B1 (en) 2000-11-20 2002-09-10 Bristol-Myers Squibb Company Process for water soluble azole compounds
EP2130540A1 (de) 2008-06-02 2009-12-09 Sandoz AG Pharmazeutische Zusammensetzungen mit einer kristallinen Form von Posaconazol
EP2141159A1 (de) 2008-07-03 2010-01-06 Sandoz AG Kristalline Form von Posaconazol
CA2767489A1 (en) 2009-07-09 2011-01-13 Sandoz Ag A crystalline form of posaconazole
CN102234267A (zh) * 2010-04-21 2011-11-09 中国科学院上海药物研究所 新型三氮唑类抗真菌化合物、其药物组合物及其制备方法和用途
MX337804B (es) 2010-05-19 2016-03-18 Sandoz Ag Proceso para la preparacion de hidrazinas quirales.
EP2571868B1 (de) * 2010-05-19 2016-05-04 Sandoz AG Reinigung von posaconazol und posaconazol-zwischenprodukten
MX2012013331A (es) * 2010-05-19 2013-02-01 Sandoz Ag Purificacion de posaconazol y de intermediarios de posaconazol.
EP2571871B1 (de) 2010-05-19 2017-06-21 Sandoz AG Verfahren zur Herstellung von chiralen Triazolonen
WO2012172015A1 (en) 2011-06-16 2012-12-20 Sandoz Ag Process for the preparation of a chiral compound
WO2015011224A1 (en) 2013-07-25 2015-01-29 Sandoz Ag Improved process for the preparation of crystalline form iv of posaconazole
ITMI20132114A1 (it) 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
CN104370894A (zh) * 2014-10-21 2015-02-25 江苏恒盛药业有限公司 无定型泊沙康唑的制备工艺
CN105622591B (zh) * 2014-11-06 2018-09-21 博瑞生物医药（苏州）股份有限公司 一种新型三唑类抗真菌药物的制备方法
US10106531B2 (en) 2014-12-05 2018-10-23 Pulmocide Limited Compound useful to treat mycoses
AU2016263669B2 (en) 2015-05-21 2020-04-30 Pulmocide Limited Antifungal 4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4- difluorophenyl)tetrahydrofuran-3-yl) methoxy)-3-methylphenyl)piperazin-1-yl)-N- (2-hydroxycyclohexyl) benzamide, or a pharmaceutically acceptable salt thereof
CN106432338A (zh) * 2015-08-08 2017-02-22 陕西合成药业股份有限公司 泊沙康唑衍生物、合成和在长效制剂中的用途
CN105606736A (zh) * 2016-01-27 2016-05-25 重庆华邦制药有限公司 分离测定泊沙康唑中间体z1及其有关物质的方法
CN107033186B (zh) * 2016-02-04 2020-06-09 武汉朗来科技发展有限公司 泊沙康唑衍生物、其药物组合物和用途
CN105949278B (zh) * 2016-03-30 2019-12-06 南京曼杰生物科技有限公司 一种取代的四氢呋喃水溶性衍生物及其应用
CN106986787A (zh) * 2017-03-30 2017-07-28 成都绿林科技有限公司 一种泊沙康唑中间体的合成方法
CN106866459A (zh) * 2017-03-30 2017-06-20 成都绿林科技有限公司 一种抗真菌药物中间体的制备方法
CN110938093B (zh) * 2018-09-21 2022-08-19 华创合成制药股份有限公司 一种泊沙康唑磷酸酯单胆碱盐及其制备方法和用途
CN113666915B (zh) * 2021-08-27 2022-08-16 江苏海洋大学 一种泊沙康唑中间体的制备方法
CN114315811B (zh) * 2021-11-19 2024-04-30 江苏恒盛药业有限公司 一种三氮唑类似物化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103558A0 (en) * 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
CN1064685C (zh) * 1993-12-21 2001-04-18 先灵公司 四氢呋喃抗真菌剂
PT741737E (pt) * 1994-01-24 2000-04-28 Janssen Pharmaceutica Nv Antifungicos do tipo azole soluveis em agua

Also Published As

Publication number Publication date
CA2197672A1 (en) 1996-12-05
CZ59497A3 (en) 1997-08-13
EP0773941A1 (de) 1997-05-21
TW357146B (en) 1999-05-01
HUP9701690A2 (hu) 1998-03-02
HUP9701690A3 (en) 1998-04-28
AR002751A1 (es) 1998-04-29
NO971218L (no) 1997-03-17
MX9701229A (es) 1997-05-31
SK27097A3 (en) 1997-09-10
IL118464A (en) 2000-08-13
ES2199291T3 (es) 2004-02-16
PL319635A1 (en) 1997-08-18
CN1161038A (zh) 1997-10-01
HK1008821A1 (en) 1999-05-21
NO971218D0 (no) 1997-03-17
WO1996038443A1 (en) 1996-12-05
DE69628117T2 (de) 2004-04-01
EP0773941B1 (de) 2003-05-14
ATE240319T1 (de) 2003-05-15
IL118464A0 (en) 1996-09-12
AU5928096A (en) 1996-12-18
CN1073109C (zh) 2001-10-17
CA2197672C (en) 2011-05-17
NZ309281A (en) 1998-07-28

Similar Documents

Publication Publication Date Title
DE69628117D1 (de) Antifungale tetrahydrofurane
DE69609678D1 (de) Synchronisiervorrichtung-Kupplung-Anordnung
DE69622196D1 (de) Motorträgeranordnung
ATA135896A (de) Skibob
DK0760210T3 (da) Nultids-klemmeindretning
ATE198470T1 (de) Alkenyl-benzoylguanidine
DE29505385U1 (de) Gestänge
ATE240972T1 (de) Cyclopeptolide
FI950718A (fi) Alusta
KR970047909U (ko) 전화기용 조이스틱
NO951410D0 (no) Anleggsmaskin
FI955570A0 (fi) Seen
KR970028193U (ko) 개량신문
KR960038266U (ko) 개량 권척
KR970005654U (ko) 환경캔
NO951804D0 (no) Turnus-oversiktsanordning
KR960030307U (ko) 다시
BR7500192U (pt) Parasitofiltro
BR7502714U (pt) Impresscard
BR7500437U (pt) Girolight
BR7501836U (pt) Protecheque
BR7502025U (pt) Kantil
BR7500825U (pt) Chutegol
BR7502098U (pt) T-compacto
BR7500040U (pt) Raquet mastit

Legal Events

Date Code Title Description
8364 No opposition during term of opposition